Cencora said it priced December 2, 2024 4.625% Senior Notes due 2027 $500,000,000, 4.850% Senior Notes due 2029 $600,000,000 and 5.150% Senior Notes due 2035 $700,000,000 in an underwritten registered public offering.

1. 01

   Cencora said it priced December 2, 2024 4.625% Senior Notes due 2027 $500,000,000, 4.850% Senior Notes due 2029 $600,000,000 and 5.150% Senior Notes due 2035 $700,000,000 in an underwritten registered public offering.

2. 02

   The company said it expects to close the sale of the notes on December 9, 2024, subject to the closing conditions in the underwriting agreement. It estimates net proceeds of about $1.79 billion after deducting underwriting discounts and offering expenses.

3. 03

   The company said it plans to use the net proceeds to finance part of the previously disclosed acquisition of a majority stake in Retina Consultants of America, to pay related fees and expenses, and for general corporate purposes. The offering is not contingent on completion of the acquisition.

4. 04

   The company said the notes are senior unsecured obligations of the company and were registered on November 26, 2024 with the SEC under Form S-3 shelf registration statement (Registration Statement No. 333-283481).

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.